Why the study?
CKD on peritoneal dialysis is accompanied by elevated markers of oxidative stress, inflammation, and endothelial dysfunction, which represent a key triad for the development and progression of atherosclerosis.
Does diabetes increase markers of oxidative stress, inflammation, and endothelial dysfunction in CKD patients on peritoneal dialysis?
Does diabetes increase markers of oxidative stress, inflammation, and endothelial dysfunction in CKD patients on peritoneal dialysis?
Diabetic patients with CKD on peritoneal dialysis exhibit significantly worse profiles of oxidative stress, inflammation, and endothelial dysfunction compared to their nondiabetic counterparts, suggesting a higher atherogenic risk.
Answers are grounded in this paper and cite their sources.
May indicate heightened markers in diabetic PD patients; leaves open causal links to atherosclerosis.
Chronic kidney disease (CKD) is a low-grade inflammatory state which is accom-panied by elevated markers of oxidative stress, inflammatory, and endothelial dysfunction in patients on peritoneal dialysis (PD). These represent a key triad for the development and progression of atherosclerosis. The present study assessed the markers of oxidative stress, inflammatory and endothelial dysfunction in diabetic and non-diabetic CKD patients on PD. A cross-sectional study was undertaken on 100 CKD patients on PD, of whom 52 patients were nondiabetic and 48 were diabetic patients. Blood samples were estimated for malondialdehyde (MDA) and ferric reducing ability of plasma (FRAP) as markers of oxidative stress; interleukin (IL)-6, high-sensitivity C-reactive protein (hs-CRP), and fibrinogen as inflammatory markers; and markers of endothelial dysfunction such as nitric oxide (NO), carotid wall intimal medial thickness (CIMT), and number of plaques, among others. The MDA levels increased and FRAP levels decreased in both diabetic and nondiabetic CKD patients on PD. The levels of IL-6, hs-CRP, fibrinogen, NO, CIMT, and the number of plaques were significantly higher in diabetic patients than in nondiabetic CKD patients on PD. The lipid profile was significantly atherogenic in diabetic patients compared with nondiabetics CKD patients. The results showed increased oxidative stress, inflammation, and endothelial dysfunction in diabetic patients compared with nondiabetics CKD patients on PD.
No takes yet. Share an insight, caveat, or question.
Nannapaneni et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: